Physician profile
Herluf Lund
NPI 1750318085
$7,386.70
in general payments reported to CMS, 2019-2025
16 companies · $1,079 in 2025
The $1,079 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,121 · 2020: $214 · 2021: $524 · 2022: $1,622 · 2023: $1,508 · 2024: $318 · 2025: $1,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,257 · Consulting Fee: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,256.68 |
| Consulting Fee | $648.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,994.27 | 2019-2022 | |
| Abbvie INC. | $1,731.60 | 2023-2025 | |
| Davol INC. | $692.00 | 2022-2023 | Phasix Mesh |
| Mentor Worldwide LLC | $317.56 | 2019-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $317.03 | 2019-2022 | |
| Integra Lifesciences Corporation | $292.60 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Galderma Laboratories, L.P. | $265.06 | 2019-2025 | |
| Rti Surgical, INC | $154.23 | 2025 | |
| Revance Therapeutics, INC. | $135.72 | 2024-2025 | Daxxify |
| Tepha INC | $126.74 | 2019 | |
| Becton, Dickinson and Company | $114.65 | 2022 | |
| Axogen | $108.15 | 2019 | |
| Motiva USA, LLC | $60.62 | 2025 | |
| Merz North America, INC. | $46.54 | 2022-2023 | Xeomin |
| Kci USA, INC. | $16.40 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $13.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herluf Lund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.